The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
The CDC’s recent decision to harmonize recommendations for respiratory viruses has the public and infectious disease societies in support. The Infectious Diseases Society of America (IDSA) supports the CDC’s harmonization in a recent blog post.IDSA’s immediate past president Carlos del Rio has supported rolling back COVID-19 incubation recommendations as early as December 2021 when he was an advisor at Delta Airlines and petitioned the CDC to drop the isolation rates for vaccine breakthrough infections from 10 to 5 days due to concerns it “…may significantly impact (Delta’s) workforce and operations.” Currently, IDSA is supporting the CDC in dropping the isolation time to 0 days for asymptomatic carriers. In view of protracted viral shedding in patients who have become symptom-free after infection (11% had positive cultures at 10 days) and a 40 to 50% rate of asymptomatic infections, some have concerns regarding this decision.
The lower-case fatality rate of the Omicron variant is overridden by its high infectivity, increasing the chances of becoming severely sick from participating in social activities. The Omicron wave was associated with some of the highest community rates of deaths and hospitalizations during the pandemic. SARS-CoV-2 is much more infectious than influenza, possibly approaching that of measles. SARS-CoV-2 also has a higher incidence of death and long-term sequelae, including autoimmune diseases.
However, we need to ask: Should SARS-CoV-2, with its frequent period of asymptomatic spread and high infectivity, be harmonized with other non-ACE2 receptor respiratory viruses? And is COVID-19 even a respiratory illness, as opposed to a multi-system disease that can masquerade in many different forms, similar to syphilis?
A better prevention harmonization may well be with the measles and polio viruses.
Measles and polio cases mainly affect the young, but as a senior citizen, I can testify that life and livelihood at all ages are just as precious.
The impending loss of herd immunity for measles is an ominous development. Measles is a DNA virus and thus has a lower mutation rate than SARS-CoV-2, but it still can mutate. Historically, there was a rapid uptake of the measles vaccine, and the spread was halted. But now the virus is spreading and mutating. Already, a strain of measles has been detected in Italy which escapes tests. If we keep on spreading the measles virus, we risk it developing resistance to the vaccine.
COVID-19 is still ravaging our society, with over 200 deaths each week and over 20,000 individuals in the hospital each day. And the tolls of long COVID may be mounting, not decreasing. During the first week of February 2024, 6.8% of all adults are experiencing long COVID symptoms, up from 5.3% during the week of October 18 to 30, 2023. In Sweden, a country that had very few COVID-19 interventions, a major insurance company, If, reported that after the pandemic, 1 in 3 young adults are experiencing brain fog.
We need to ask, if we are allowing asymptomatic individuals with COVID-19 to mingle in our community, how can we effectively message the public to increase their vigilance and vaccination rates for diseases with similar or even less severe outcomes?
The mantra that “we are now in a better place” gives a misleading impression. We are still in a dangerous place that requires increased vigilance and strategies to prevent infectious diseases.
I started my medical career attending to cancer patients. I would hear the pleading from patients and their friends, trying to minimize the disease and avoid treatments. But you cannot bargain with cancer, nor can you with COVID-19. The virus does not care what society is willing to do; it only exists to reproduce and, in its wake, is left with death and disability.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.
Environmental Hygiene: Air Pressure and Ventilation: Negative vs Positive Pressure
December 10th 2024Learn more about how effective air pressure regulation in health care facilities is crucial for controlling airborne pathogens like tuberculosis and COVID-19, ensuring a safer environment for all patients and staff.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies